Stay updated on Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial page.

Latest updates to the Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe two screenshots show the same study details page with no meaningful updates to the study content or layout.SummaryDifference0.3%

- Check38 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference3%

- Check45 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not alter core content or other critical data.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.0.2 was added, replacing v3.0.1. The Back to Top link was removed.SummaryDifference0.2%

- Check66 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%

- Check73 days agoChange DetectedThe web page has updated its facility name and location details, specifically adding information about St. John's, Canada, and new medical conditions and treatments, while removing previous location terms and outdated drug information.SummaryDifference2%

Stay in the know with updates to Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial page.